Measles and the central nervous system. (Q48704387)

14 February 2018

title

Measles and the central nervous system. (English)

1 reference

14 February 2018

1 reference

A Kipps

1

1 reference

14 February 2018

G Dick

series ordinal

2

1 reference

14 February 2018

J W Moodie

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 December 1983

1 reference

14 February 2018

published in

The Lancet

1 reference

14 February 2018

volume

2

1 reference

14 February 2018

issue

8364

1 reference

14 February 2018

page(s)

1406-1410

1 reference

14 February 2018

Inclusion bodies in measles encephalitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

A case of acute measles meningoencephalitis with virus isolation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Isolation of infectious measles virus in measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Epidemiology of subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Slow Virus Infections of the Nervous System: Virological, Immunological and Pathogenetic Considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Measles virus and chronic neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Subacute sclerosing panencephalitis: an epidemiologic study in Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Subacute measles encephalitis complicating Hodgkin's disease in an adult

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Measles inclusion-body encephalitis in a child with treated acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Letter: Atypical measles encephalitis in leukaemic children in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Encephalopathy following measles infection in children with chronic illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Atypical measles infections in leukaemic children on immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Fatal measles encephalopathy with retinopathy during cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Immunosuppressive Measles Encephalitis in a Patient With a Renal Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Immunosuppressive measles encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: the relationship to subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Early onset of subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

An infantile case of subacute sclerosing panencephalitis with an abnormal ganglioside pattern in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Adult Onset of Subacute Sclerosing Panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

1 reference

7 January 2021

Two cases of rapidly progressive subacute sclerosing panencephalitis. Neuropathological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

SSPE, measles virus, and the matrix protein: Report of a case with unusual immunochemical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Measles virus and subacute neurological disease: an unusual presentation of measles inclusion body encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Atypical subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Acute measles encephalitis of the delayed type

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Acute delayed measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Postinfectious and vaccinal encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Abnormal levels of antibodies to measles-virus proteins in patient with mental retardation and seizures 24 years after measles encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

Diagnosis of subacute panencephalitis. The value and availability of measles antibody determinations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2883%2990932-7

7 January 2021

10.1016/S0140-6736(83)90932-7

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

6140503

1 reference

14 February 2018